MétaCan
ENFR
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

Export CSVExport JSONAPI query

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
→
Sort
Language
Type
Field
Venue
Bioanalysis
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

112 results · 1 filter active ·
Results by year
20092025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
112 works in the cohort · of 4,299,418page 1 of 3

Labels cover 1 of 112 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 112 of 112 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundunlabeled
Advances in Metabolite Identification
David S. Wishart
2011· review· en· Bioanalysis· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
276
citations
afffundunlabeled
2020 White Paper on Recent Issues in Bioanalysis: Vaccine Assay Validation, qPCR Assay Validation, QC for CAR-T Flow Cytometry, NAb Assay Harmonization and ELISpot Validation ( <u>Part 3</u> –Recommendations on Immunogenicity Assay Strategies, NAb Assays, Biosimilars and FDA/EMA Immunogenicity Guidance/Guideline, Gene &amp; Cell Therapy and Vaccine Assays)
Bart Corsaro, Tong‐Yuan Yang, Rocio Murphy, Ivo Sonderegger, Andrew Exley, Sylvie Bertholet +47 more
2021· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · metaresearchconsensus · none
61
citations
affunlabeled
Recommendations on qPCR/ddPCR Assay Validation by GCC
Mark Wissel, Martin Poirier, Christina Satterwhite, John Lin, Rafiq Islam, Jennifer Zimmer +37 more
2022· article· en· Bioanalysis· Biochemistry, Genetics and Molecular Biology
machine prediction:candidate · noneconsensus · none
52
citations
affunlabeled
2018 White Paper on Recent Issues in Bioanalysis: <i>‘A Global Bioanalytical Community Perspective on Last Decade of Incurred Samples Reanalysis (ISR)’</i> (Part 1 – Small Molecule Regulated Bioanalysis, Small Molecule Biomarkers, Peptides &amp; Oligonucleotide Bioanalysis)
Jan Welink, Yuanxin Xu, Eric Yang, Amanda Wilson, Neil Henderson, Lina Luo +47 more
2018· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · metaresearchconsensus · none
39
citations
afffundunlabeled
2021 White Paper on Recent Issues in Bioanalysis: TAb/NAb, Viral Vector CDx, Shedding Assays; CRISPR/Cas9 &amp; CAR-T Immunogenicity; PCR &amp; Vaccine Assay Performance; ADA Assay Comparability &amp; Cut Point Appropriateness ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccine Assays; Immunogenicity of Biotherapeutics and Novel Modalities; Integrated Summary of Immunogenicity Harmonization)
LiNa Loo, Shannon Harris, Mark Milton, Meena Meena, Wibke Lembke, Flora Berisha +56 more
2022· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
36
citations
affunlabeled
2021 White Paper on Recent Issues in Bioanalysis: Mass Spec of Proteins, Extracellular Vesicles, CRISPR, Chiral Assays, Oligos; Nanomedicines Bioanalysis; ICH M10 Section 7.1; Non-Liquid &amp; Rare Matrices; Regulatory Inputs ( <u>Part 1A</u> – Recommendations on Endogenous Compounds, Small Molecules, Complex Methods, Regulated Mass Spec of Large Molecules, Small Molecule, PoC &amp; <u>Part 1B</u> - Regulatory Agencies' Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)
Surinder Kaur, Stephen C. Alley, Matt Szapacs, Amanda Wilson, Eugene Ciccimaro, Dian Su +70 more
2022· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
29
citations
affunlabeled
2020 White Paper on Recent Issues in Bioanalysis: BAV Guidance, CLSI H62, Biotherapeutics Stability, Parallelism Testing, CyTOF and Regulatory Feedback ( <u>Part 2A</u> –Recommendations on Biotherapeutics Stability, PK LBA Regulated Bioanalysis, Biomarkers Assays, Cytometry Validation &amp; Innovation <u>Part 2B</u> –Regulatory Agencies’ Inputs on Bioanalysis, Biomarkers, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)
Susan Spitz, Yan Zhang, Sally Fischer, Kristina McGuire, Ülrike Sommer, Lakshmi Amaravadi +75 more
2021· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
26
citations
affunlabeled
2021 White Paper on Recent Issues in Bioanalysis: ISR for Biomarkers, Liquid Biopsies, Spectral Cytometry, Inhalation/Oral &amp; Multispecific Biotherapeutics, Accuracy/LLOQ for Flow Cytometry ( <u>Part 2</u> – Recommendations on Biomarkers/CDx Assays Development &amp; Validation, Cytometry Validation &amp; Innovation, Biotherapeutics PK LBA Regulated Bioanalysis, Critical Reagents &amp; Positive Controls Generation)
Sarah Hersey, Steve Keller, Joel Mathews, Lindsay King, Abbas Bandukwala, Flora Berisha +65 more
2022· article· en· Bioanalysis· Engineering
machine prediction:candidate · metaresearchconsensus · none
25
citations
affunlabeled
2023 White Paper on Recent Issues in Bioanalysis: ISR for ADA Assays, the Rise of dPCR vs qPCR, International Reference Standards for Vaccine Assays, Anti-AAV TAb Post-Dose Assessment, NanoString Validation, ELISpot as Gold Standard <u>(Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity &amp; Technologies; Biotherapeutics Immunogenicity &amp; Risk Assessment; ADA/NAb Assay/Reporting Harmonization)
Johanna Mora, Rachel Palmer, Leslie Wagner, Bonnie Wu, Michael A. Partridge, Meena Meena +51 more
2024· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
20
citations
affunlabeled
2022 White Paper on Recent Issues in Bioanalysis: Fda Draft Guidance on Immunogenicity Information in Prescription Drug Labeling, Lnp &amp; Viral Vectors Therapeutics/Vaccines Immunogenicity, Prolongation Effect, Ada Affinity, Risk-Based Approaches, Ngs, Qpcr, Ddpcr Assays ( <u>Part 3</u> – Recommendations on Gene Therapy, Cell Therapy, Vaccines Immunogenicity &amp; Technologies; Immunogenicity &amp; Risk Assessment of Biotherapeutics and Novel Modalities; NAb Assays Integrated Approach)
Luying Pan, Johanna Mora, Karl Walravens, Leslie Wagner, Shirley Hopper, LiNa Loo +62 more
2023· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
16
citations
affunlabeled
Recommendations on ELISpot Assay Validation by the GCC
Rafiq Islam, Jennifer Vance, Martin Poirier, Jennifer Zimmer, Ardeshir Khadang, Dave Williams +41 more
2022· article· en· Bioanalysis· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
13
citations
afffundunlabeled
2023 White Paper on Recent Issues in Bioanalysis: Deuterated Drugs; LNP; Tumor/FFPE Biopsy; Targeted Proteomics; Small Molecule Covalent Inhibitors; Chiral Bioanalysis; Remote Regulatory Assessments; Sample Reconciliation/Chain of Custody <u>(PART 1A</u> – Recommendations on Mass Spectrometry, Chromatography, Sample Preparation Latest Developments, Challenges, and Solutions and BMV/Regulated Bioanalysis <u>PART 1B</u> - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV, Biomarkers/IVD/CDx/BAV, Immunogenicity, Gene &amp; Cell Therapy and Vaccine)
Mike Baratta, Wenying Jian, Shawna Hengel, Surinder Kaur, Jennifer Cunliffe, Jason Boer +77 more
2024· article· en· Bioanalysis· Pharmacology, Toxicology and Pharmaceutics
machine prediction:candidate · noneconsensus · none
11
citations
next →

How this was built: Screen · Findings · About